ASPIRE - A Study Promoting the Influenza Response in the Elderly v1

• Research type

  Research Study

• Full title

  A trial aimed at enhancing immunity to Influenza in elderly individuals through reversal of immune senescence mediated by herpes virus infection.

• IRAS ID

  65689

• Sponsor organisation

  University of Birmingham

• Eudract number

  2011-000092-13

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  Flu is a major health concern and although flu vaccination is given every year to people over the age of 60 years, a lot of people make a poor immune response to the vaccine. It is now clear that one reason why older people can develop problems with their immune system is that they carry chronic viral infections such as cytomegalovirus (CMV). The immune system has to work very hard to control these infections and this ??diverts?? them away from new infections such as flu. We propose to use anti-viral drugs, that are often used to treat diseases such as cold sores, to dampen down CMV and therefore allow the immune system to recover from fighting the virus. We anticipate that the efficiency of the immune response will then improve and make a stronger response to flu vaccination. In the first part of the study we will find the dose of tablet that is most effective in this effect and see how long it needs to be taken for. In a second section we will use this dose in a large cohort of elderly donors who are receiving their influenza vaccine. We will therefore test if this intervention is effective. If proven, this form of treatment could be valuable in a wide range of clinical conditions and help to promote healthy ageing.

• REC name

  East Midlands - Leicester Central Research Ethics Committee

• REC reference

  11/H0406/10

• Date of REC Opinion

  14 Feb 2011

• REC opinion

  Favourable Opinion